Press release
Drug Eluting Beads Market Forecast By End-use Industry 2017-2025
Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor.Request Report for TOC @ https://www.persistencemarketresearch.com/toc/19075
Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
Drug Eluting Beads Market: Drivers and Restraint
The global drug eluting beads market is primarily driven by the increasing prevalence of liver diseases. Increasing awareness among people regarding the benefits of drug eluting beads therapy is also expected to drive the growth of the global drug eluting beads market. However, lack of skilled physicians is expected to restrain the market growth.
Drug Eluting Beads Market: Overview
The global drug eluting beads market is expected to show a significant growth over the forecast period. The number of population with the liver diseases has grown significantly and increasing demand for invasive treatment is expected to drive the growth of drug eluting beads market. In addition, the increasing adoption of this new technology by the patient is also driving the growth of drug eluting beads market.
Drug Eluting Beads Market: Region Wise Outlook
The global drug eluting beads market can be segmented into regions: North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America region dominates the global drug eluting beads market. High adoption of new technologies in the region is expected to be the factor for the growth of drug eluting beads market. Europe is expected to be the second biggest market for the global drug eluting beads market. Asia Pacific is expected to be the moderate growing region in the drug eluting beads market. Moreover, Latin America and Middle East and Africa are also expected to show moderate growth for drug eluting beads market during the forecast period.
Drug Eluting Beads Market: Key Players
The major key players of the global drug eluting beads market are Biocompatibles UK Ltd, BTG International Ltd., Merit Medical Systems, Inc, CeloNova BioSciences, Inc, ABK Biomedical, Inc., Boston Scientific Corporation, Medtronic, Inc., Merit Medical Systems, Inc., Surefire Medical, Inc., Terumo Corporation and others.
Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/19075
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug Eluting Beads Market Forecast By End-use Industry 2017-2025 here
News-ID: 939019 • Views: …
More Releases from Persistence Market Research
Mechanical Mine Clearance System Market Set for Steady Growth at 4.4% CAGR Throu …
The mechanical mine clearance system market occupies a highly specialized yet critically important position within the global defense, humanitarian, and post-conflict reconstruction landscape. Mechanical mine clearance systems are engineered solutions designed to detect, detonate, neutralize, or remove landmines and unexploded ordnance (UXO) from contaminated terrain using armored, remotely operated, or semi-autonomous machinery. These systems are increasingly relied upon in environments where manual demining is either too dangerous, time-consuming, or inefficient.…
Bagging Equipment Market Poised for Steady Expansion at a 4.9% CAGR Through 2033 …
The bagging equipment market plays a critical role in modern packaging and material-handling operations, supporting industries that rely on efficient, accurate, and hygienic packaging of bulk and semi-bulk products. Bagging equipment is widely used for filling and sealing bags containing food grains, powders, chemicals, construction materials, fertilizers, animal feed, pharmaceuticals, and consumer goods. As manufacturers across sectors face mounting pressure to improve throughput, reduce labor dependency, and maintain consistent packaging…
Industrial Automation Market Poised for Steady Growth, Reaching US$448.3 Bn by 2 …
The industrial automation market has evolved into a cornerstone of modern manufacturing and process industries, driven by the need for higher productivity, consistent quality, and cost optimization. Automation technologies-including industrial control systems, robotics, sensors, and software platforms-enable manufacturers to replace or augment manual processes with intelligent, machine-driven operations. As global industries face rising labor costs, supply chain volatility, and increasing pressure to improve sustainability metrics, automation has transitioned from a…
Home Healthcare Market to Reach US$954.0 Bn by 2033 at 7.8% CAGR - Persistence M …
The global home healthcare market is undergoing a structural transformation as healthcare systems pivot toward decentralized, patient-centric care delivery models. The market is projected to expand from US$ 580.8 billion in 2026 to US$ 954.0 billion by 2033, registering a robust CAGR of 7.8% during the forecast period. This growth trajectory builds upon a historical CAGR of 6.2% recorded between 2020 and 2025, reflecting sustained momentum across both developed and…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
